Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$1.3 - $2.15 $123 - $204
-95 Reduced 0.82%
11,427 $19,000
Q4 2023

Feb 12, 2024

SELL
$1.4 - $2.46 $1,615 - $2,838
-1,154 Reduced 9.1%
11,522 $22,000
Q2 2023

Aug 11, 2023

BUY
$4.26 - $6.92 $53,999 - $87,717
12,676 New
12,676 $53,000
Q2 2021

Aug 17, 2021

SELL
$4.72 - $7.15 $57,466 - $87,051
-12,175 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$5.13 - $7.24 $2,924 - $4,126
570 Added 4.91%
12,175 $67,000
Q4 2020

Feb 16, 2021

BUY
$5.18 - $6.03 $60,113 - $69,978
11,605 New
11,605 $61,000

Others Institutions Holding XAIR

About Beyond Air, Inc.


  • Ticker XAIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 29,888,000
  • Market Cap $11.4M
  • Description
  • Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...
More about XAIR
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.